Diabetic Retinopathy to Diabetic Retinal Disease: Using retinal structural and functional testing to characterize the effects of diabetes on the retina
Presented by Roomasa Channa, MD
University of Wisconsin-Madison
We begin at 6 p.m. with networking, appetizers, and cash bar, followed by the meeting and dinner at 6:45 p.m. Members are encouraged to invite guests.
This talk will review the limitations of the current diabetic retinopathy (DR) classification which relies heavily on structural imaging and misses early neurovascular dysfunction, limiting its predictive and clinical utility. We will cover ongoing work on evaluating retinal function using handheld electroretinogram in patients with diabetes and the use of AI in developing more comprehensive markers of disease activity.
Dr. Roomasa Channa is an Associate Professor in the Department of Ophthalmology and Visual Sciences and Co-Director of the Artificial Intelligence (AI) unit at the University of Wisconsin-Madison. Dr. Channa is a retina surgeon with a research focus on studying factors associated with vision loss in patients with diabetic retinal diseases. Her research focuses on using retinal imaging to study diabetic eye diseases and technology such as AI to improve access to eye care. Her work had been funded by numerous organizations including the National Eye Institute, National Aeronautical and Space Association (NASA), Department of Defense, the Johns Hopkins Children’s Center, and the Veterans Affairs hospital.
Meeting sponsored by:
